Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Oct 1997, 2628-2633, Vol 35, No. 10
WH Goessens, JW Mouton, WI van der Meijden, S Deelen, TH van Rijsoort-Vos, N Lemmens-den Toom, HA Verbrugh and RP Verkooyen
We compared the Gen-Probe transcription-mediated amplification assay (AMP
CT), the Abbott LCx assay, and the Roche COBAS AMPLICOR assay for the
detection of Chlamydia trachomatis in a mixed population in urine samples.
First-void urine, urethral specimens, and cervical specimens in females
were obtained from 1,000 patients (544 males and 456 females) visiting the
outpatient sexually transmitted disease clinic of our hospital. The
prevalence of C. trachomatis infection was 7.7% as determined by tissue
culture of urethral and cervical specimens. The sensitivities of LCx, COBAS
AMPLICOR, and AMP CT compared to cell culture were 79, 86, and 78%,
respectively. Sensitivity and specificity were recalculated by using a new
"gold standard", i.e., a sample was considered to be true positive if two
or more techniques yielded positive results. Specimens positive only by
cell culture or positive in only one commercial amplification technique
were retested by a previously described in-house PCR. After discordance
analysis the sensitivities of LCx, COBAS AMPLICOR, and AMP CT were 84, 93,
and 85%, respectively. Specificity exceeded 99% for all three assays. With
each method the sensitivity was lower for urine samples from females
compared to urine samples from males. By application of this new gold
standard, existing differences between methods are highlighted; future
evaluations of new techniques should be validated against two or more
amplification assays.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine
Department of Medical Microbiology and Infectious Diseases, University Hospital Rotterdam, The Netherlands. Goessens@bacl.azr.nl
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|